Equities

AlphaHelix Molecular Diagnostics AB (publ)

AlphaHelix Molecular Diagnostics AB (publ)

Actions
Health CareMedical Equipment and Services
  • Price (SEK)0.306
  • Today's Change-0.014 / -4.38%
  • Shares traded16.76k
  • 1 Year change-54.87%
  • Beta--
Data delayed at least 15 minutes, as of Apr 30 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Events & Activity

  • ALPH:AKT trading volume exceeds daily average by +300.05%
  • ALPH:AKT price moved over -8.75% to 0.292
  • ALPH:AKT price falls below 15-day moving average to 0.292 at 12:43 BST

Key statistics

On Tuesday, AlphaHelix Molecular Diagnostics AB (publ) (ALPH:AKT) closed at 0.306, 53.77% above the 52 week low of 0.199 set on Mar 12, 2024.
52-week range
Today
0.199Mar 12 20240.79Jun 07 2023
Open0.294
High0.306
Low0.292
Bid0.274
Offer0.304
Previous close0.32
Average volume17.06k
Shares outstanding63.40m
Free float52.30m
P/E (TTM)--
Market cap19.40m SEK
EPS (TTM)-0.1794
SEK
Data delayed at least 15 minutes, as of Apr 30 2024.
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
S&P Global Market Intelligence Short Selling Activity © S&P Global Market Intelligence. All rights reserved.
Although S&P Global Market Intelligence has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of S&P Global Market Intelligence on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.